Landscape Capital Management L.L.C. acquired a new position in Doximity, Inc. (NYSE:DOCS – Free Report) during the 3rd quarter, HoldingsChannel reports. The fund acquired 32,836 shares of the company’s stock, valued at approximately $931,000.
Several other large investors have also recently made changes to their positions in the company. Global Retirement Partners LLC grew its stake in Doximity by 6,017.7% during the 3rd quarter. Global Retirement Partners LLC now owns 11,073 shares of the company’s stock valued at $314,000 after acquiring an additional 10,892 shares in the last quarter. Edgestream Partners L.P. purchased a new stake in Doximity in the 3rd quarter valued at $6,926,000. HighTower Advisors LLC raised its holdings in shares of Doximity by 1.0% during the 3rd quarter. HighTower Advisors LLC now owns 37,067 shares of the company’s stock worth $1,050,000 after acquiring an additional 352 shares during the period. Intech Investment Management LLC raised its holdings in shares of Doximity by 107.1% during the 3rd quarter. Intech Investment Management LLC now owns 35,592 shares of the company’s stock worth $1,009,000 after acquiring an additional 18,405 shares during the period. Finally, Bessemer Group Inc. grew its holdings in shares of Doximity by 79.8% in the third quarter. Bessemer Group Inc. now owns 1,910 shares of the company’s stock valued at $54,000 after purchasing an additional 848 shares during the period. 87.19% of the stock is currently owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In related news, Director Watkin Phoebe L. Yang sold 1,290 shares of the company’s stock in a transaction dated Wednesday, September 30th. The stock was sold at an average price of $26.71, for a total value of $34,455.90. Following the completion of the sale, the director directly owned 24,744 shares of the company’s stock, valued at $660,912.24. This represents a 4.96% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Kira Wampler sold 2,000 shares of the company’s stock in a transaction on Monday, November 2nd. The shares were sold at an average price of $32.89, for a total transaction of $65,780.00. Following the completion of the sale, the director owned 27,923 shares of the company’s stock, valued at approximately $918,387.47. This trade represents a 6.68% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 25,224 shares of company stock worth $801,442 in the last three months. 31.80% of the stock is owned by company insiders.
Analysts Set New Price Targets
DOCS has been the topic of several recent analyst reports. JPMorgan Chase & Co. boosted their target price on shares of Doximity from $26.00 to $31.00 and gave the company a “neutral” rating in a report on Friday, August 7th. Evercore set a $35.00 price target on shares of Doximity in a research report on Tuesday, September 29th. Raymond James Financial reaffirmed an “outperform” rating and set a $38.00 price objective on shares of Doximity in a research report on Friday, October 16th. Royal Bank Of Canada boosted their price objective on Doximity from $28.00 to $34.00 and gave the company an “outperform” rating in a report on Friday, November 6th. Finally, Piper Sandler reiterated an “overweight” rating and set a $47.00 price target (up from $42.00) on shares of Doximity in a research note on Friday, August 7th. Eight equities research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $30.59.
Get Our Latest Report on Doximity
Doximity Stock Down 3.4%
NYSE DOCS opened at $29.64 on Friday. Doximity, Inc. has a 52 week low of $17.15 and a 52 week high of $51.85. The stock has a market capitalization of $5.29 billion, a PE ratio of 41.16, a price-to-earnings-growth ratio of 32.84 and a beta of 1.29. The firm has a 50 day moving average of $30.23 and a two-hundred day moving average of $25.19.
Doximity (NYSE:DOCS – Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The company reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.17. The business had revenue of $174.54 million during the quarter. Doximity had a net margin of 21.12% and a return on equity of 15.80%. Doximity’s revenue for the quarter was up 3.6% on a year-over-year basis. During the same period last year, the firm posted $0.45 earnings per share. On average, equities research analysts expect that Doximity, Inc. will post 0.72 earnings per share for the current fiscal year.
Doximity Profile
Doximity, Inc. operates a digital platform designed for medical professionals, including physicians and other clinicians. Its services support professional networking, medical news and research discovery, career development, and communication among healthcare professionals. The company also offers clinical workflow tools, including Doximity Dialer, which enables clinicians to make calls and conduct video visits using a work number, as well as digital fax and document services. Doximity provides marketing and recruitment solutions to healthcare organizations and life sciences companies.
Featured Articles
- Five stocks we like better than Doximity
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NYSE:DOCS – Free Report).
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.
